Nightingale Health: Possible breakthrough moves further away Analyysi 30.09.2022 12:39 Nightingale Health Nightingale’s H2 figures were weak throughout. The targets for the new fiscal year were also more conservative than our expectations and suggested that the potential for stronger growth is further down the road than we assumed. Therefore, we lowered our estimates considerably.
Inderes - Lowers guidance ranges: new EBITA mid-point 34% below SEB estimate Analyysi 28.09.2022 15:17 Inderes Group Inderes issued a profit warning, as its virtual event business (outside the core client sector) continues to lag behind its targets. The key impression is that the previous year's strong performance by Flik was supported by Covid and future years' growth must be built on a lower base.
Exel: Growth opportunities through a global production network Analyysi 28.09.2022 14:22 Exel Composites Exel has been quite successful in its operational activities over the present year, but with a significantly weakened macro picture and short visibility of the business, there is still considerable uncertainty about the company's near-term performance.
Anora: Expected return mainly based on dividends Analyysi 27.09.2022 13:06 Anora Anora is the Nordic market leader in wines and spirits. Organic growth is modest due to a stable market, and we expect earnings growth in the next few years to come mainly from acquisitions and synergies, as well as the leveling off of raw material costs.
Fiskars: Slowing demand puts pressure on earnings Analyysi 26.09.2022 9:47 Fiskars Group We expect slowing consumer demand to be visible in Fiskars' development over the coming year. With our estimates the performance improvement indicated by the company’s guidance will be very modest. We do, however, believe that Fiskars' performance is structurally much higher than before COVID.
